Objective: To discuss current and potential treatment options for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA). Data Sources: A MEDLINE search (1966-January 2007 ...
MSSA) Administered intravenously, once-daily dose, rapidly bactericidal, not active against VISA, no efficacy in pneumonia, potential muscle toxicity Tigecycline cSSSI (MRSA, MSSA), complicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback